MLL REARRANGEMENT

Clinical trials for MLL REARRANGEMENT explained in plain language.

Never miss a new study

Get alerted when new MLL REARRANGEMENT trials appear

Sign up with your email to follow new studies for MLL REARRANGEMENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug cocktail tested for aggressive leukemia that has returned

Disease control Recruiting now

This early-stage trial is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and tolerable for patients. It focuses on adults with acute myeloid leukemia (AML) that has returned or not responded to prior therapy and has specific …

Matched conditions: MLL REARRANGEMENT

Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control

Last updated Mar 16, 2026 15:26 UTC

MLL REARRANGEMENT

Get alerted when new MLL REARRANGEMENT trials appear

New drug cocktail tested for aggressive leukemia that has returned